These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Conference updates show promising drug data. AIDS Alert; 1997 Nov; 12(11):125-6. PubMed ID: 11364769 [TBL] [Abstract][Full Text] [Related]
23. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance]. MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980 [No Abstract] [Full Text] [Related]
27. [Drug combination therapy for children infected with HIV/AIDS--own experience]. Prandota-Schoepp A; Klinowska-Skupniewska J Przegl Epidemiol; 2001; 55 Suppl 3():135-41. PubMed ID: 11984940 [TBL] [Abstract][Full Text] [Related]
28. Newly approved PI provides treatment options. AIDS Alert; 1997 Jun; 12(6):68-9. PubMed ID: 11364360 [TBL] [Abstract][Full Text] [Related]
29. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1. Krogstad P; Lee S; Johnson G; Stanley K; McNamara J; Moye J; Jackson JB; Aguayo R; Dieudonne A; Khoury M; Mendez H; Nachman S; Wiznia A; Clin Infect Dis; 2002 Apr; 34(7):991-1001. PubMed ID: 11880966 [TBL] [Abstract][Full Text] [Related]
31. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection. Hoffmann F; Funk M; Linde R; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH; Wintergerst U Eur J Med Res; 2002 Jul; 7(7):330-4. PubMed ID: 12176683 [TBL] [Abstract][Full Text] [Related]
32. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up. Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062 [TBL] [Abstract][Full Text] [Related]
33. LaCARP opens clinical trials to patients of all primary care providers. Fac Notes (New Orleans La); 1998; 10(2):9. PubMed ID: 11365129 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children. Moolasart P; Likanonsakul S Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426 [TBL] [Abstract][Full Text] [Related]
36. Drug studies for children and adults. Vazquez E Posit Aware; 1998; 9(3):15-6. PubMed ID: 11365482 [TBL] [Abstract][Full Text] [Related]
37. Any toxic relief in sight? The induction/maintenance approach to therapy. Gomez E Newsline People AIDS Coalit N Y; 1998 Sep; ():33. PubMed ID: 11367488 [TBL] [Abstract][Full Text] [Related]
38. Rescue me. Simmons P Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705 [TBL] [Abstract][Full Text] [Related]
39. Protease inhibitors at Retroviruses Conference: Agouron's results. James JS AIDS Treat News; 1996 Mar; (no 242):5-6. PubMed ID: 11363194 [TBL] [Abstract][Full Text] [Related]